Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
FDA has extended its review timeline for the supplemental New Drug Application (sNDA) for FILSPARI (sparsentan) in focal segmental glomerulosclerosis (FSGS), with a new PDUFA target action date of April 13, 2026
Novo's Path To The First GLP-1 Weight Loss Pill | ISPE Targets Uncertainty In Pharma's AI Novo's Path To The First GLP-1 Weight Loss Pill The era of the "weight loss pill" officially arrived on December 22, 2025, when the FDA approved oral Wegovy, crowning Novo Nordisk the winner of the high-stakes race for the first daily GLP-1 tablet
When semaglutide's patents expire beginning in 2030, this may further open up an opportunity for more companies to enter the market, making the product more readily available
18 The most bioavailable forms of B12 are methylcobalamin, hydroxocobalamin, and adenosylcobalamin
Stay Hydrated: The Importance of Water When Using Ozempic Slim Transformation Jul 25, 2024 2 min read Ozempic (semaglutide) is the medication we use to support your Slim Transformation
US$ 26.79
US$ 27.57
US$ 20.94
US$ 20.61
US$ 20.11
US$ 21.23
US$ 24.33
US$ 29.70
